advertisement
11.4 Prostaglandins (35)
Showing records 1 to 25
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins11301 Impact of prostaglandin-F2α-analogues and carbonic anhydrase inhibitors on central corneal thickness -- a cross-sectional study on 403 eyes
Viestenz A; Martus P; Schlotzer-Schrehardt U; Langenbucher A; Mardin CY
Klinische Monatsblätter für Augenheilkunde 2004; 221: 753-756
11304 A comparison of the effects of dorzolamide/timolol fixed combination versus latanoprost on intraocular pressure and pulsatile ocular blood flow in primary open-angle glaucoma patients
Januleviciene I; Harris A; Kagemann L; Siesky B; McCranor L
Acta Ophthalmologica Scandinavica 2004; 82: 730-737
11308 A three-year prospective, randomized and open comparison between latanoprost and timolol in Japanese normal-tension glaucoma patients
Tomita G; Araie M; Kitazawa Y; Tsukahara S
Eye 2004; 18: 984-989
11492 Persistency and treatment failure in newly diagnosed open angle glaucoma patients in the United Kingdom
Zhou Z; Althin R; Sforzolini BS; Dhawan R
British Journal of Ophthalmology 2004; 88: 1391-1394
11554 The comparative cardiovascular, pulmonary, ocular blood flow, and ocular hypotensive effects of topical travoprost, bimatoprost, brimonidine, and betaxolol
Inan UU; Ermis SS; Orman A; Onrat E; Yucel A; Ozturk F; Asagidag A; Celik A
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 293-310
11307 Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy
Stewart WC; Stewart JA; Day DG; Sharpe ED; Jenkins JN
Eye 2004; 18: 990-995
11302 Short term efficacy and safety in glaucoma patients changed to the latanoprost 0.005%/timolol maleate 0.5% fixed combination from monotherapies and adjunctive therapies
Hamacher T; Schinzel M; Scholzel-Klatt A; Neff HM; Maier H; Schlaffer G; Beausencourt E; Jutte M; Scholz R; Lorger C
British Journal of Ophthalmology 2004; 88: 1295-1298
11305 Short and long-term hypotensive effect of timolol-gel and latanoprost instillation in normal-tension glaucoma
Hashimoto T; Hara T; Takahashi Y; Kubota S; Kubota M; Tsuru T
Nippon Ganka Gakkai Zasshi 2004; 108: 477-481
11300 Daytime diurnal curve comparison between the fixed combinations of latanoprost 0.005%/timolol maleate 0.5% and dorzolamide 2%/timolol maleate 0.5%
Konstas AGP; Kozobolis VP; Lallos N; Christodoulakis E; Stewart JA; Stewart WC
Eye 2004; 18: 1264-1269
11228 Diurnal intraocular pressure reduction with latanoprost 0.005% compared to timolol maleate 0.5% as monotherapy in subjects with exfoliation glaucoma
Konstas AGP; Mylopoulos N; Karabatsas CH; Kozobolis VP; Diafas S; Papapanos P; Georgiadis N; Stewart WC
Eye 2004; 18: 893-899
11303 Comparison of the nocturnal effects of once-daily timolol and latanoprost onintraocular pressure
Liu JH; Kripke DF; Weinreb RN
American Journal of Ophthalmology 2004; 138: 389-395
11306 Comparison of the effects of latanoprost and timolol gel-forming solution on diurnal variation of intraocular pressure in normal-tension glaucoma
Nakamoto K; Yasuda N; Nanno M; Fukuda T
Nippon Ganka Gakkai Zasshi 2004; 108: 401-407
11442 A study of iridectomy histopathologic features of latanoprost- andnon-latanoprost-treated patients
Albert DM; Gangnon RE; Zimbric ML; Damico CM; Fisher MR; Gleiser J,; Grossniklaus HE; Green WR
Archives of Ophthalmology 2004; 122: 1680-1685
11436 Analysis of irises with a latanoprost-induced change in iris color
Arranz-Marquez E; Teus MA; Saornil MA; Mendez MC; Gil R
American Journal of Ophthalmology 2004; 138: 625-630
11354 Detection of the free acid of bimatoprost in aqueous humor samples from human eyes treated with bimatoprost before cataract surgery
Camras CB; Toris CB; Sjoquist B; Milleson M; Thorngren JO; Hejkal TW; Patel N; Barnett EM; Smolyak R; Hasan SF
Ophthalmology 2004; 111: 2193-2198
11393 Prostaglandin analogs and blood-aqueous barrier integrity: a flare cell meter study
Cellini M; Caramazza R; Bonsanto D; Bernabini B; Campos EC
Ophthalmologica 2004; 218: 312-317
11342 Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma
Christiansen GA; Nau CB; McLaren JW; Johnson DH
Ophthalmology 2004; 111: 1658-1662
11260 Effect of latanoprost on intraocular pressure in mice lacking the prostaglandin FP receptor
Crowston JG; Lindsey JD; Aihara M; Weinreb RN
Investigative Ophthalmology and Visual Science 2004; 45: 3555-3559
11422 A persistency and economic analysis of latanoprost, bimatoprost, or beta-blockers in patients with open-angle glaucoma or ocular hypertension
Day DG; Schacknow PN; Sharpe ED; Ellyn JC; Kulze III JC; Threlkeld AB; Jones ED; Brown RH; Jenkins JN; Stewart WC
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 383-392
11438 Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkeyeyes
Gagliuso DJ; Wang RF; Mittag TW; Podos SM
Archives of Ophthalmology 2004; 122: 1342-1347
11460 Effect of different dose schedules of 0.15% unoprostone isopropyl on intraocular pressure and pupil size in the glaucomatous beagle
Gelatt KN; MacKay EO; Dashiell T; Biken-A
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 411-420
11405 Latanoprost and pigmentation
Grierson I; Jonsson M; Cracknell K
Japanese Journal of Ophthalmology 2004; 48: 602-612
11415 Intraocular pressure, safety and quality of life in glaucoma patients switching to latanoprost from adjunctive and monotherapy treatments
Haverkamp F; Wuensch S; Fuchs M; Stewart WC
European Journal of Ophthalmology 2004; 14: 407-415
11424 Short-term effects of bimatoprost in glaucoma patients from an outpatient clinic
Iester M; Perdicchi A; Venturino G; Rolando M; Traverso CE; Leonardi E; Calabria G
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 393-400
11421 Ocular hypotensive efficacy of travoprost in patients unsuccessfully treated with latanoprost
Kaback M; Geanon J; Katz G; Ripkin D; Przydryga JT
Current Medical Research and Opinion 2004; 20: 1341-1345
